This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based

Novavax, Inc. today celebrated the first shipment of R21/Matrix-M™ malaria vaccine by its partner, Serum

Novavax's updated JN.1 COVID-19 vaccine is active against current circulating strains, including KP.2